Journolist is Alive and Well

Last week I asked the question about whether it was ok for columnists (Ezra Klein to be exact) to basically adjust reality to fit their agenda. Essentially Paul Ryan’s concept is similar to Medicare Part D which, while being yet another entitlement, is also built on choice and competition AND has surpassed expectations as it concerns costs/prices/customer satisfaction.
Klein essentially found “facts” to deny those surpassed expectations. Why? Because he would never want to see a similar plan for all of Medicare via Paul Ryan. Why? I’m guessing because some Journolist somewhere decided that the left wing media needs to be against it.

This week James C. Capretta calls him out big time.

The program is now in its sixth year of operation, and it has exceeded all expectations. Some 90 percent of Medicare participants are now in secure drug coverage of some sort, and public-opinion surveys continue to show that seniors are very satisfied with the new program. Most important, the drug benefit’s costs for the first decade are coming in 42 percent below what was predicted at the time of enactment.
As this evidence of success has piled up, the critics largely and wisely went silent, realizing they had little ground to stand on.

But that began to change when Rep. Paul Ryan proposed a broader reform of Medicare that is modeled on the Part D success story. Now the critics have little choice but to try to discredit Part D lest they lose the battle over the future of Medicare. And so the attacks have resumed.

The only problem is that the critics’ arguments still have no basis in fact.

Take the latest attack from Washington Post blogger Ezra Klein. He recently argued: (a) that spending on prescription drugs throughout the health-care system (that is, not just in Medicare) is also far below previous expectations, which proves that Part D’s market-based design had nothing to do with costs’ coming in under budget; (b) that, regardless of what has happened to date, future Part D spending is expected to rise rapidly, thus undermining claims of cost discipline; and (c) that Part D premiums are 57 percent higher in 2011 than in 2006.

Unfortunately for Klein, each of these criticisms is easily dismissed.

Go, read the whole thing and then quit bothering with Mr. Klein. He’s apparently a tool.

(ht JG)